glp 3 retatrutide (GLP-3) – Y&P Labs Retatrutide (Reta GLP-3) - 99%+
Description
The humanized allele contains human GLP-1R cDNA with a preserved human intron 2, a region containing potential regulatory elements conserved across species
This approval offers a new and effective treatment option for adults with active disease who are receiving standard therapy, with the added benefit of a shorter 90-minute infusion time for patients
Lancet Diabetes Endocrinol 2021;9:825-36.ArticlePubMed 129
Long-term safety data is still being collected through ongoing trials
If you're unsure, your doctor can give guidance specific to your protocol
Li CJ, Yu Q, Yu P, Yu TL, Zhang QM, Lu S, et al
